Clinical Trial Update: GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers [Phase 4]

View source ↗

Summary

Phase 4 trial update for GrafixPRIME in the treatment of diabetic foot ulcers (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• GrafixPRIME

Snippet

Sponsor: Osiris Therapeutics | Conditions: Foot Ulcer, Diabetic | Phase 4 | Status: COMPLETED